CD4 and neoplasm: For instance, iron-oxide nanoparticles contributed to the reprogramming of tumour-associated macrophages to a pro-inflammatory M1-like phenotype, suppressing tumour growth, and efficiently delivered the ovalbumin antigen (OVA) to dendritic cells, thus activating CD4+ and CD8+ effector T cells in animal models of solid tumours [573].